Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 2 institutions in 1 country.
Herbert Guimarães de Sousa SilvaLaboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo CEP 05503-900, SP, Brazil.
Marcia Regina FranzolinLaboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo CEP 05503-900, SP, Brazil.ORCID 0000-0003-0654-639X
Geovana Ferreira Dos AnjosLaboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo CEP 05503-900, SP, Brazil.
Angela Silva BarbosaLaboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo CEP 05503-900, SP, Brazil.ORCID 0000-0002-6458-9489
Luis Fernando Dos SantosCentro de Bacteriologia, Núcleo de Doenças Entéricas, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 355, São Paulo CEP 01246-000, SP, Brazil.ORCID 0000-0002-6158-5247
Kaique Ferrari MirandaLaboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo CEP 05503-900, SP, Brazil.
Ronaldo Maciel MarquesLaboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo CEP 05503-900, SP, Brazil.
Matilde Costa Lima de SouzaLaboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo CEP 05503-900, SP, Brazil.
Roxane Maria Fontes PiazzaLaboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo CEP 05503-900, SP, Brazil.ORCID 0000-0003-0068-8506
Marta de Oliveira DomingosLaboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo CEP 05503-900, SP, Brazil.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
O55 Polysaccharides Are Good Antigen Targets for the Formulation of Vaccines against O55 STEC and Capsulated aEPEC Strains. · full record | OpenQuestion